Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 24 (2) , 147-157
- https://doi.org/10.1016/j.semnephrol.2003.11.003
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Albuminuria and poor glycemic control predict mortality in NIDDMDiabetes, 1995
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Prognosis in diabetic nephropathy.BMJ, 1989
- Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.BMJ, 1987
- EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHYThe Lancet, 1983
- Long-term antihypertensive treatment inhibiting progression of diabetic nephropathyBMJ, 1982
- A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathyDiabetologia, 1981
- The clinical course of diabetic nephropathyJAMA, 1976
- Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive TreatmentScandinavian Journal of Clinical and Laboratory Investigation, 1976